Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Online master’s degrees in engineering and education from Purdue again rank among the nation’s finest. Four of Pur ...

Eli Lilly said it received Food and Drug Administration ... is now approved to treat two types of inflammatory bowel disease in the U.S., the Indianapolis company said Wednesday.

Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for two types of ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first ...

Eli Lilly announced preliminary fourth-quarter revenue of roughly $13.5 billion, or $400 million below the low end of its guidance, driven by slower-than-expected US market growth and lower ...

Shares of Eli Lilly and Co. fell more than 7% in midday trading Tuesday after the Indianapolis company ... We continued to make progress on our manufacturing build-out, and U.S. supply across ...

CEO Dave Ricks told CNBC that the company has "tons of supply coming online" and that it will add more manufacturing capacity. Eli Lilly cut its revenue guidance on Tuesday as it said demand for ...

Eli Lilly (LLY ... to make progress on our manufacturing build-out, and U.S. supply across all doses of tirzepatide was available throughout Q4," said Lilly CEO David Ricks in a statement.

Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue estimate stands at $13.95B. "While the U.S ...